Movano Health Reports Q1 2024 Financial Results and Provides Business Update

Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance process Plans launch of Evie Med and focuses on B2B opportunities Plans arterial blood pressure study for June Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif., May 15, 2024 /PRNewswire/ –…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks